Does chronic kidney disease modify the association between body mass index and cardiovascular disease risk factors?

Journal of Nephrology

Volumn 25, Issue 3, 2012, Pages 317-324

  Bansal, Nisha ^a   Vittinghoff, Eric ^a   Plantinga, Laura ^a   Hsu, Chi Yuan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BMI; Cardiovascular; CKD; Risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME VARIABLE; PRESCRIPTION; RACE; SENSITIVITY ANALYSIS; SEX; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; LINEAR MODELS; LIPIDS; MALE; MIDDLE AGED; NONLINEAR DYNAMICS; NUTRITION SURVEYS; OBESITY; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 84863302150     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/JN.2011.8454     Document Type: Article

References (41)

1. Brown CD, Higgins M, Donato KA, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res. 2000;8:605-619.
2. Fleischmann E, Teal N, Dudley J, May W, Bower JD, Salahudeen AK. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int. 1999;55:1560-1567.
3. Kopple JD, Zhu X, Lew NL, Lowrie EG. Body weight-forheight relationships predict mortality in maintenance hemodialysis patients. Kidney Int. 1999;56:1136-1148.
4. Leavey SF, McCullough K, Hecking E, Goodkin D, Port FK, Young EW. Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2001;16:2386-2394.
5. Johansen KL, Young B, Kaysen GA, Chertow GM. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr. 2004;80:324-332.
6. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005;81:543-554.
7. Kalantar-Zadeh K. Causes and consequences of the reverse epidemiology of body mass index in dialysis patients. J Ren Nutr. 2005;15:142-147.
8. Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis. 2007;49: 581-591.
9. Kovesdy CP, Anderson JE. Reverse epidemiology in patients with chronic kidney disease who are not yet on dialysis. Semin Dial. 2007;20:566-569.
10. Elsayed EF, Tighiouart H, Weiner DE, et al. Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis. 2008;52:49-57.
11. Kwan BC, Murtaugh MA, Beddhu S. Associations of body size with metabolic syndrome and mortality in moderate chronic kidney disease. Clin J Am Soc Nephrol. 2007;2: 992-998.
12. Obermayr RP, Temml C, Gutjahr G, et al. Body mass index modifies the risk of cardiovascular death in proteinuric chronic kidney disease. Nephrol Dial Transplant. 2009;24:2421-2428.
13. Evans M, Fryzek JP, Elinder CG, et al. The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. Am J Kidney Dis. 2005;46:863-870.
14. Shulman NB, Ford CE, Hall WD, et al; The Hypertension Detection and Follow-up Program Cooperative Group. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the hypertension detection and follow-up program. Hypertension. 1989;13(Suppl):I80-I93.
15. Levey AS, Coresh J, Greene T, et al; Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247-254.
16. National Health and Nutrition Examination Survey Laboratory Procedure Manual. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2001.
17. Arnaud C, Braunersreuther V, Mach F. Toward immunomodulatory and anti-inflammatory properties of statins. Trends Cardiovasc Med. 2005;15:202-206.
18. Arnaud C, Veillard NR, Mach F. Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis. Curr Drug Targets Cardiovasc Haematol Disord. 2005;5:127-134.
19. Blanco-Colio LM, Tuñón J, Martín-Ventura JL, Egido J. Antiinflammatory and immunomodulatory effects of statins. Kidney Int. 2003;63:12-23.
20. Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov. 2005;4:977-987.
21. Kleemann R, Kooistra T. HMG-CoA reductase inhibitors: effects on chronic subacute inflammation and onset of atherosclerosis induced by dietary cholesterol. Curr Drug Targets Cardiovasc Haematol Disord. 2005;5:441-453.
22. Kumar S, Raftery M, Yaqoob M, Fan SL. Anti-inflammatory effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors (statins) in peritoneal dialysis patients. Perit Dial Int. 2007;27:283-287.
23. Lahera V, Goicoechea M, de Vinuesa SG, et al. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins. Curr Med Chem. 2007;14:243-248.
24. Montecucco F, Mach F. Update on statin-mediated antiinflammatory activities in atherosclerosis. Semin Immunopathol. 2009;31:127-142.
25. Schonbeck U, Libby P. Inflammation, immunity, and HMGCoA reductase inhibitors: statins as antiinflammatory agents? Circulation. 2004;109(Suppl 1):11118-11126.
26. Levey AS, Stevens LA, Schmid CH, et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
27. Ilyas B, Dhaun N, Markie D, et al. Renal function is associated with arterial stiffness and predicts outcome in patients with coronary artery disease. QJM. 2009;102:183-191.
28. Lacy P, Carr SJ, O'Brien D, et al. Reduced glomerular filtration rate in pre-dialysis non-diabetic chronic kidney disease patients is associated with impaired baroreceptor sensitivity and reduced vascular compliance. Clin Sci (Lond). 2006;110:101-108.
29. Taal MW, Sigrist MK, Fakis A, Fluck RJ, McIntyre CW. Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5. Nephron Clin Pract. 2007;107:c177-c181.
30. Tetzner F, Scholze A, Wittstock A, Zidek W, Tepel M. Impaired vascular reactivity in patients with chronic kidney disease. Am J Nephrol. 2008;28:218-223.
31. Kawamoto R, Kohara K, Tabara Y, et al. An association between decreased estimated glomerular filtration rate and arterial stiffness. Intern Med. 2008;47:593-598.
32. Matsuda N, Takei T, Fujiu A, Ogawa T, Nitta K. Arterial stiffness in patients with non-diabetic chronic kidney disease (CKD). J Atheroscler Thromb. 2009;16:57-62.
33. Dengo AL, Dennis EA, Orr JS, et al. Arterial destiffening with weight loss in overweight and obese middle-aged and older adults. Hypertension. 2010;55:855-861.
34. Rider OJ, Tayal U, Francis JM, et al. The effect of obesity and weight loss on aortic pulse wave velocity as assessed by magnetic resonance imaging. Obesity (Silver Spring). 2010;18:2311-2316.
35. Seifalian AM, Filippatos TD, Joshi J, Mikhailidis DP. Obesity and arterial compliance alterations. Curr Vasc Pharmacol. 2010;8:155-168.
36. Berl T, Hunsicker LG, Lewis JB, et al; Collaborative Study Group. Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol. 2005;16:2170-2179.
37. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE. Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Nephrol Dial Transplant. 2006;21:1257-1262.
38. Miller DC, Trulson MF, McCann MB, White PD, Stare FJ. Diet, blood lipids and health of Italian men in Boston. Ann Intern Med. 1958;49:1178-1200.
39. Ridderstråle M, Gudbjörnsdottir S, Eliasson B, Nilsson PM, Cederholm J; Steering Committee of the Swedish National Diabetes Register (NDR). Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register. J Intern Med. 2006;259:314-322.
40. Vierhapper H, Nardi A, Grösser P. Prevalence of paradoxically normal serum cholesterol in morbidly obese women. Metabolism. 2000;49:607-610.
41. Lo JC, Go AS, Chandra M, Fan D, Kaysen GA. eGFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD. Am J Kidney Dis. 2007;50: 552-558.